Reata Pharmaceuticals, Inc. (RETA) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is bullish — 4 Buy, 6 Hold.
The consensus price target is $62.67 (low: $27.00, high: $115.00), representing a downside of 63.6% from the current price $172.36.
RETA Stock — 12-Month Price Forecast
$62.67
▼ -63.64% Downside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for Reata Pharmaceuticals, Inc., the average price target is $62.67, with a high forecast of $115.00, and a low forecast of $27.00.
The average price target represents a -63.64% change from the last price of $172.36.
Highest Price Target
$115.00
Average Price Target
$62.67
Lowest Price Target
$27.00
RETA Analyst Ratings
Hold
Based on 10 analysts giving stock ratings to Reata Pharmaceuticals, Inc. in the past 3 months
